Providers / 11.16.26

Third-Party Tested Compounded Medications: A Quality Checklist for Prescribers

Strive technician in sterile garb holding a tray of sealed vials in a cleanroom.

Eight Questions to Ask Your 503A Compounding Pharmacy About Testing, Sourcing, and Quality

When you send a prescription to a compounding pharmacy, there’s a lot that happens before that medication reaches your patient. Where did the active pharmaceutical ingredient (API) come from? How was the formula developed? Was it tested? What supports the beyond-use date (BUD)?

Trust in compounding has to be earned. Prescribers haven’t always had a clear view into how medications are made, tested, or verified.

That’s why transparency matters. A pharmacy should be able to show you where its ingredients come from, how its formulas are developed, what it tests, and what happens when something doesn’t meet its standards.

Third-party testing is a big part of that. As a 503A pharmacy, Strive compounds medications for individual patients pursuant to a valid prescription. The goal isn’t to replace commercially available medications. It’s to give prescribers another option when they make the clinical determination that a patient needs something different.

Here's what to look for and what to ask.

Strive team member reviewing quality data at a workstation.

What Does "Third-Party Tested" Actually Mean?

Third-party testing means sending a preparation to an independent, qualified lab to see if it meets the right specifications. Depending on the preparation, that might mean testing potency, sterility, bacterial endotoxins, impurities, or a combination of them.

The important thing is that the pharmacy isn’t checking its own work.

But “third-party tested” can mean different things from one pharmacy to another. Ask what they test, how often they test it, which labs they use, and what happens when something comes back outside specification.

Accreditation gives you another way to evaluate a pharmacy. Strive is PCAB (ACHC) and NABP accredited, VPP inspected, and LegitScript certified. You can learn what each of those credentials means and how to verify them in our guide to choosing a compounding pharmacy partner.

1. Where Do the APIs Come From?

Every compounded medication starts with its active pharmaceutical ingredients, so that’s a good place to start asking questions. Where do the APIs come from? How does the pharmacy choose its suppliers? Does someone review the full certificate of analysis (COA) for every lot?

At Strive, every API manufacturer has to be FDA-registered, and every COA is reviewed and inspected. If we find a difference in purity, potency, or residual solvents, we account for it when building the formula so the final preparation matches its labeled strength.

We also document each step from the time an API arrives through the finished preparation. That means we can trace what went into a medication and where it came from.

Question to ask: “Can you show me a COA for an ingredient in a formula I prescribe?”

2. How Is a Formula Built Before It Reaches Patients?

We don’t add a new formulation just because an ingredient is getting attention. There needs to be a clinical reason for it, and the science needs to support it.

That work starts with research and development (R&D). Before a formula is ever prepared for a patient, our team looks at the ingredients, the research behind them, how they work together, and whether the finished preparation can be made consistently.

Here’s what that process looks like:

  • Submission: New formulation requests come through designated members of our team.
  • Science review: R&D and Clinical review the research, dosing, how the ingredients work, and potential clinical applications. Supply Chain, Quality, Product, and Compliance also review areas like ingredient purity and regulatory requirements.
  • Formula build: Before anything is weighed, we look at the active and inactive ingredients, base compatibility, pH, solubility, water activity, and texture.
  • Prototype and testing: We build and refine prototypes in a controlled lab. Our internal standard requires APIs to be weighed within a certain percent of the target quantity. The formulas are then sent out for third-party testing.
  • Quarantine: R&D lots stay quarantined and separate from anything prepared for patients.

Question to ask: “Why is each ingredient in this formula?”

3. What Does Sterile Compounding Oversight Look Like?

USP <797> sets standards for sterile compounding, including the cleanroom environment, beyond-use dating, environmental monitoring, and personnel qualifications. That means things like air and surface sampling happen regularly, and anyone working with sterile preparations has to stay current on aseptic technique qualifications.

But the cleanroom is only part of the picture. Testing matters too.

Strive’s sterile program includes routine third-party testing:

  • USP <71> sterility testing
  • USP <85> bacterial endotoxin testing
  • Method suitability validation to make sure the testing method itself is reliable
  • Randomized quantitative potency testing

Question to ask: “Which tests do you run on sterile preparations, how often, and through which labs?”

Gloved hands leveling powder into a capsule-filling plate during nonsterile compounding

4. How Is Potency Testing Handled?

Potency testing checks whether the amount of active ingredient in the finished preparation matches the labeled strength. The important questions are who does the testing, how often it happens, and what happens when something comes back outside specification.

At Strive, R&D sets the acceptable potency range for each formulation, and qualified third-party labs perform the testing. That starts during formulation validation and continues after a formula is in use.

Every week, randomized batches are tested for potency. In nonsterile compounding, each compounder is also potency tested on every dosage form every six months to verify technique, with results tracked over time across our sites. And every nonsterile batch produced on automated equipment is potency tested before release.

When a result comes back out of specification, the batch is placed on hold and not dispensed while our Quality team investigates. That investigation includes a review of the API lot and its COA, the compounding record, the equipment, and the technique used. Following the investigation, the batch is disposed of. Depending on the findings, additional corrective actions may include retraining or updates to the formula or compounding process. The investigation and corrective actions are documented and tracked by our Continuous Improvement team.

Question to ask: “What happens when a potency test comes back out of specification?”

5. What Controls Apply to Non-sterile Compounding?

USP <795> sets standards for nonsterile compounding, while USP <800> covers how hazardous drugs are handled. But standards are only part of it. You also want to know what checks happen while a medication is actually being prepared.

At Strive, two pharmacists independently verify the Master Formulation Record before compounding starts. Ingredients are weighed and checked against that record, and those weights are documented in the Compounding Record.

Before anything is packaged, the preparation is also checked for texture, uniformity, and appearance against standards set by our R&D team.

Question to ask: “Who verifies a formula before it’s compounded, and how is that documented?”

Strive technician weighing a filled container on a balance during nonsterile compounding”

6. Does the Pharmacy Go Beyond the Baseline When the Formulation Calls for It?

Some formulations need more than routine testing. Specialized delivery systems, such as liposomal formulations, may need additional testing to understand things like particle size, stability, drug loading, and how the drug is released.

Every liposomal formulation is different, and so are the methods used to characterize it. Strive has performed characterization testing on select formulations, and those results apply only to the specific formulations and tests involved. Methods can include:

  • Nanoparticle tracking analysis (NTA): Uses laser illumination and video to track individual particles and measure liposome size, size distribution, and concentration.
  • Cryo-TEM (cryogenic transmission electron microscopy): Images rapidly frozen samples so individual liposomes can be viewed in a hydrated, near-native state, including their shape, structure, and any aggregation.
  • Encapsulation efficiency: Measures how much drug is incorporated into the liposomes relative to free drug.
  • Zeta potential: Measures the surface charge of liposomes in a dispersion, a property that influences how they interact with one another and their surroundings.
  • In vitro drug release: Measures how a drug is released from liposomes over time under controlled laboratory conditions.

These tests describe the physical characteristics of a formulation. They don’t establish safety, effectiveness, or how a product will perform in the body.

Question to ask: “Which formulations get advanced testing, and why?”

7. How Are Beyond-Use Dates Supported?

Beyond-use dates (BUDs) tell you how long a compounded medication can be used when it’s stored properly. At Strive, we establish BUDs based on USP standards and guidance, including USP <1191>.

When a formulation has an extended BUD past USP guidance, we don’t just pick a longer date. It has to be supported by stability data using a stability-indicating analytical method.

Question to ask: “Is this BUD based on USP standards, or is it supported by stability data?”

8. What Happens When Testing Points to a Change?

Testing only matters if you do something with what you learn. When an issue comes up, the pharmacy should be able to trace it, figure out what happened, and make changes when needed.

At Strive, our Continuous Improvement (CI) team tracks product issues, investigates deviations, and works with our teams on formulation updates. Technicians are also retrained every year on technique, calculations, preparation methods, and current USP standards.

If the data shows that something needs to change, we change it.

Question to ask: “Tell me about a formulation you changed, and why.”

Your Testing Checklist at a Glance

When you’re evaluating a compounding pharmacy, these are the questions worth asking:

  • Which third-party tests do you run, how often, and which labs do you use?
  • Do you review the full COA for every lot? What happens if something is off with purity, potency, or residual solvents?
  • What testing does a new formula go through before it’s used for patients?
  • What happens when a potency, sterility, or endotoxin test comes back outside specification?
  • Who verifies a formula before compounding starts?
  • When does a formulation need more advanced testing?
  • What data supports an extended beyond-use date?
  • When testing uncovers an issue, how does that lead to changes in the formula or process?

For a broader look at evaluating a compounding pharmacy, including licensure, capacity, provider support, and advocacy, see our 13-question due-diligence checklist.

Ask Your Pharmacy to Show Its Work

Your patients aren't statistics, and the preparations you prescribe for them deserve scrutiny. At Strive, we welcome it. Transparency is a strength, not a liability, and we're as committed to elevating the compounding industry as we are to sharing our own standard. We meet the standard, and we’re determined to help redefine it.

Ask where the ingredients come from. Ask to see the testing. Ask why each ingredient is in the formula. And if a pharmacy can’t give you a clear answer, that tells you something.

If a formulation isn't the right fit for your patient, we'll have an honest conversation about why and work alongside you to explore what is. Want to see our work? Reach out to your Strive representative or contact us to speak with a pharmacist.

Partner With Strive, a Compounding Pharmacy That Shows Its Work

Quality at Strive isn’t a checkbox: it’s the foundation. Learn how our sourcing, testing, and quality systems are designed to support providers, clinics, and telehealth teams.

See what Strive can do for your practice

Strive compounding pharmacy team in protective garb in a nonsterile compounding lab.

Third-Party Tested Compounded Medications: FAQs for Prescribers

What is a 503A compounding pharmacy?

A 503A compounding pharmacy prepares medications for individual patients pursuant to a valid prescription. Compounding is meant to give prescribers another option when a patient is determined to have a clinical need for something different from a commercially available medication can offer. Strive Pharmacy is a 503A pharmacy. For a broader overview, see what a compounding pharmacy is.

What does “third-party tested” mean for compounded medications?

It means a preparation is sent to an independent, qualified lab to check whether it meets specifications. Depending on the preparation, testing may cover potency, sterility, bacterial endotoxins, or impurities. The term can mean different things from one pharmacy to the next, so prescribers can ask what is tested, how often, and by which labs.

What is a Certificate of Analysis (COA)?

A COA is a document that reports quality details for a specific lot of an active pharmaceutical ingredient (API), such as purity, potency, and residual solvents. At Strive, every COA is reviewed and inspected. Prescribers can ask to see a COA for an ingredient in a formula they prescribe.

How is potency testing different from sterility testing?

Potency testing checks whether the amount of active ingredient in a finished preparation matches the labeled strength. Sterility testing, such as USP <71>, looks for microbial contamination in sterile preparations. Strive’s sterile program also includes USP <85> bacterial endotoxin testing. 

Which USP chapters apply to compounding?

USP <797> sets standards for sterile compounding, USP <795> covers nonsterile compounding, and USP <800> covers how hazardous drugs are handled. Strive also references USP <1191> when establishing beyond-use dates (BUDs).

How are beyond-use dates (BUDs) determined?

A BUD tells you how long a compounded medication can be used when stored properly according to the label. At Strive, BUDs are assigned in accordance with applicable USP standards. An extended BUD must be supported by stability data from a stability-indicating analytical method.

Are compounded medications FDA-approved?

No. Compounded medications aren’t FDA-approved because federal law (section 503A of the FD&C Act) exempts them from new drug approval requirements when they meet the conditions of that section, including being prepared for an identified individual patient pursuant to a valid prescription. They’re prepared for an identified individual patient, not mass-produced for the market, to give prescribers another option when they determine a patient needs something different.

Disclaimer:

This information is intended for educational purposes only and does not constitute medical advice. Compounded medications are specially prepared for identified individual patient needs based on a valid prescription from a prescribing healthcare practitioner and, as such, have not been reviewed or approved by the U.S. Food and Drug Administration (FDA) for safety or efficacy. Compounded drugs are intended for patients whose prescriber has determined their medical needs are not met by an available FDA-approved drug. Prescribers should use their independent clinical judgment when determining appropriateness for individual patients.

If you are a patient, always consult your healthcare provider before starting any new medication to determine whether it is appropriate for your individual circumstances. Contact your healthcare provider with any questions regarding a medical condition.